We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIMO icon
26
Silicon Motion
SIMO
$8.68B
$33.9M 1.19%
704,483
+155,670
+28% +$6.36M
PCRX icon
27
Pacira BioSciences
PCRX
$997M
$33.1M 1.17%
553,934
-19,474
-3% -$1.14M
MMS icon
28
Maximus
MMS
$3.1B
$33.1M 1.16%
452,172
-17,815
-4% -$1.26M
AWI icon
29
Armstrong World Industries
AWI
$7.84B
$33M 1.16%
444,039
-26,873
-6% -$1.94M
IOVA icon
30
Iovance Biotherapeutics
IOVA
$2.87B
$33M 1.16%
711,398
-28,472
-4% -$1.13M
RDWR icon
31
Radware
RDWR
$1.19B
$32.9M 1.16%
1,184,752
-35,953
-3% -$898K
RVNC
32
DELISTED
Revance Therapeutics, Inc.
RVNC
$31.8M 1.12%
1,121,152
-8,864
-0.8% -$230K
LRN icon
33
Stride
LRN
$3.43B
$30.7M 1.08%
1,447,648
+93,516
+7% +$2.32M
PBH icon
34
Prestige Consumer Healthcare
PBH
$2.6B
$30.5M 1.07%
873,629
+325,677
+59% +$11.6M
CATM
35
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$30.3M 1.07%
857,332
+309,211
+56% +$7.72M
MEDP icon
36
Medpace
MEDP
$16.5B
$27.3M 0.96%
+195,984
New +$24.7M
SUPN icon
37
Supernus Pharmaceuticals
SUPN
$2.77B
$26.1M 0.92%
1,037,378
+27,764
+3% +$598K
WLDN icon
38
Willdan Group
WLDN
$1.3B
$24.6M 0.87%
590,235
-1,871
-0.3% -$65K
KPTI icon
39
Karyopharm Therapeutics
KPTI
$48M
$24M 0.85%
103,500
+6,485
+7% +$1.5M
OZK icon
40
Bank OZK
OZK
$5.61B
$23.7M 0.83%
758,401
-35,292
-4% -$953K
QLYS icon
41
Qualys
QLYS
$6.35B
$23.3M 0.82%
191,470
-8,029
-4% -$794K
PGTI
42
DELISTED
PGT, Inc.
PGTI
$22.6M 0.79%
1,109,732
-5,042
-0.5% -$93.8K
PTC icon
43
PTC
PTC
$16B
$22.5M 0.79%
188,208
+101,789
+118% +$10.1M
ARNA
44
DELISTED
Arena Pharmaceuticals Inc
ARNA
$22.3M 0.78%
+289,932
New +$21.7M
ECHO
45
DELISTED
Echo Global Logistics, Inc.
ECHO
$21M 0.74%
782,587
-33,502
-4% -$943K
WIFI
46
DELISTED
Boingo Wireless, Inc.
WIFI
$20.7M 0.73%
1,630,406
-20,428
-1% -$241K
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$18.5M 0.65%
1,369,008
-43,170
-3% -$522K
COLL icon
48
Collegium Pharmaceutical
COLL
$956M
$18.4M 0.65%
920,925
-187,294
-17% -$3.66M
AGM icon
49
Federal Agricultural Mortgage
AGM
$2.56B
$18.1M 0.64%
243,396
+25,720
+12% +$1.79M
TFX icon
50
Teleflex
TFX
$5.98B
$17.9M 0.63%
43,535
-3,000
-6% -$1.11M
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.